| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 9,952 | $31.01 | $308,636.66 | -0.1% | -8.9% | -36.6% | |
| Dec 20, 2023 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 12,000 | $28.54 | $342,480.00 | -0.3% | -0.2% | -29.9% | |
| Nov 20, 2023 | San Martin Javier65 | Chief Medical Officer | Sell | 19,700 | $28.80 | $567,315.34 | -6.8% | +1.1% | -35.6% | |
| Oct 25, 2023 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 24,338 | $24.21 | $589,222.98 | -0.6% | +43.0% | -16.9% | |
| Sep 28, 2023 | Vakiener Victoria53 | Director | Sell | 1,550 | $26.33 | $40,811.50 | -6.7% | +15.2% | -27.0% | |
| Sep 18, 2023 | Anzalone Christopher Richard60 | Chief Executive Officer | Sale+OE | 57,755 | $28.12 | $1,624,222.64 | -0.8% | -0.7% | -28.9% | |
| Jul 3, 2023 | Oliver Tracie70 | Chief Commercial Officer | Sell | 8,925 | $35.31 | $315,141.75 | -12.7% | -25.4% | -28.4% | |
| Jun 30, 2023 | Hamilton James C72 | Chief Discovery/ Trans Medicine | Sell | 3,000 | $35.53 | $106,590.00 | -1.6% | -24.5% | -27.1% | |
| Jun 27, 2023 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 15,000 | $36.20 | $543,000.00 | -3.8% | -26.1% | -27.2% | |
| May 5, 2023 | Given Douglas B66 | Director | Sell | 6,500 | $40.90 | $265,850.00 | -5.2% | -21.9% | -40.9% |